These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 267508)

  • 21. Loss of resistance to methotrexate in L5178Y mouse leukemia grown in vitro.
    Courtenay VD; Robins AB
    J Natl Cancer Inst; 1972 Jul; 49(1):45-53. PubMed ID: 5037439
    [No Abstract]   [Full Text] [Related]  

  • 22. Resistance mechanisms to methotrexate in tumors.
    Bertino JR; Göker E; Gorlick R; Li WW; Banerjee D
    Stem Cells; 1996 Jan; 14(1):5-9. PubMed ID: 8820944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The intracellular concentration dependence of antifolate inhibition of DNA synthesis in L1210 leukemia cells.
    Sirotnak FM; Donsbach RC
    Cancer Res; 1974 Dec; 34(12):332-40. PubMed ID: 4429954
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of leukemia with large doses of methotrexate and folinic acid: clinical-biochemical correlates.
    Hryniuk WM; Bertino JR
    J Clin Invest; 1969 Nov; 48(11):2140-55. PubMed ID: 5259150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical correlates of in vitro effect of methotrexate on acute leukemia blasts.
    Hryniuk WM; Bishop A; Foerster J
    Cancer Res; 1974 Oct; 34(10):2823-9. PubMed ID: 4547159
    [No Abstract]   [Full Text] [Related]  

  • 26. [Biochemistry of normal and leukemic white blood cells].
    Wilmanns W
    Z Klin Chem Klin Biochem; 1967 Sep; 5(5):233-41. PubMed ID: 4318734
    [No Abstract]   [Full Text] [Related]  

  • 27. Modes of uptake of methotrexate by normal and leukemic human leukocytes in vitro and their relation to drug response.
    Kessel D; Hall TC; Roberts D
    Cancer Res; 1968 Mar; 28(3):564-70. PubMed ID: 5238559
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect and istribution of methotrexate in the human organism during leukemia treatment].
    Wilmanns W; Martin H
    Klin Wochenschr; 1968 Mar; 46(6):281-96. PubMed ID: 5245556
    [No Abstract]   [Full Text] [Related]  

  • 29. The biochemical identification of blood and bone marrow cells of patients with acute leukemia.
    Seitz JF; Luganova IS
    Cancer Res; 1968 Dec; 28(12):2548-55. PubMed ID: 4387295
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of methotrexate on deoxyribonucleotide pools and DNA synthesis in human lymphocytic cells.
    Fridland A
    Cancer Res; 1974 Aug; 34(8):1883-8. PubMed ID: 4526300
    [No Abstract]   [Full Text] [Related]  

  • 31. On the poor correlation between the inhibition by methotrexate of dihydrofolate reductase and of deoxynucleoside incorporation into DNA.
    Roberts D; Wodinsky I
    Cancer Res; 1968 Oct; 28(10):1955-62. PubMed ID: 5696929
    [No Abstract]   [Full Text] [Related]  

  • 32. Threshold methotrexate concentration for in vivo inhibition of DNA synthesis in normal and tumorous target tissues.
    Chabner BA; Young RC
    J Clin Invest; 1973 Aug; 52(8):1804-11. PubMed ID: 4719662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolution of drug resistance in CCRF-CEM human leukemia cells selected by intermittent methotrexate exposure.
    McGuire JJ; Haile WH; Russell CA; Galvin JM; Shane B
    Oncol Res; 1995; 7(10-11):535-43. PubMed ID: 8866666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on the effects of hydroxyurea and other anticancer drugs upon pyrimidine metabolism.
    Vogler WR; Horwitz S; Groth DP
    Cancer Res; 1969 Jul; 29(7):1371-8. PubMed ID: 5256905
    [No Abstract]   [Full Text] [Related]  

  • 35. [Gene amplification].
    Taira M; Koike K
    Tanpakushitsu Kakusan Koso; 1984 Mar; 29(3):152-63. PubMed ID: 6425988
    [No Abstract]   [Full Text] [Related]  

  • 36. [Antimetabolites in the treatment of acute human leukoses. Mechanism of action and conditioning factors in the cellular response to drugs. II].
    Grignani F; Martelli M; Tonato M
    Clin Ter; 1974 Apr; 69(2):153-76. PubMed ID: 4134598
    [No Abstract]   [Full Text] [Related]  

  • 37. Evolution of methotrexate resistance of human acute lymphoblastic leukemia cells in vitro.
    Ohnuma T; Lo RJ; Scanlon KJ; Kamen BA; Ohnoshi T; Wolman SR; Holland JF
    Cancer Res; 1985 Apr; 45(4):1815-22. PubMed ID: 3856477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mechanisms of resistance to methotrexate].
    Fanin R; Aschele C; Volkendandt M; Trippett TM; Lin JT; Bertino JR
    Haematologica; 1991 Jun; 76 Suppl 3():184-7. PubMed ID: 1721601
    [No Abstract]   [Full Text] [Related]  

  • 39. Inhibition of nucleic acid synthesis by the di-n-butyl ester of methotrexate.
    Curt GA; Tobias JS; Kramer RA; Rosowsky A; Parker LM; Tattersall MH
    Biochem Pharmacol; 1976 Sep; 25(17):1943-6. PubMed ID: 985531
    [No Abstract]   [Full Text] [Related]  

  • 40. Properties of dihydrofolate reductase from a methotrexate-resistant subline of human KB cells and comparison with enzyme from KB parent cells and mouse S180 AT/3000 cells.
    Domin BA; Cheng YC; Hakala MT
    Mol Pharmacol; 1982 Jan; 21(1):231-8. PubMed ID: 7132960
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.